figshare
Browse
12885_2021_9112_MOESM3_ESM.docx (15.59 kB)

Additional file 3 of Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with metastatic or recurrent breast cancer treated using capecitabine: a retrospective study

Download (15.59 kB)
journal contribution
posted on 2022-01-14, 05:07 authored by Shigemasa Takamizawa, Tatsunori Shimoi, Natsuko Satomi-Tsushita, Shu Yazaki, Toshihiro Okuya, Yuki Kojima, Hitomi Sumiyoshi-Okuma, Tadaaki Nishikawa, Maki Tanioka, Kazuki Sudo, Emi Noguchi, Kan Yonemori
Additional file 3. Univariate analyses of progression-free survival.

History

Usage metrics

    BMC Cancer

    Categories

    Keywords

    Breast cancerCapecitabineChemotherapyEribulinNeutrophil-to-lymphocyte ratioNLRPrognostic factor

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC